# T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

> **NCT00368355** · PHASE2 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 46 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Non Hodgkins Lymphoma
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Chronic Myelogenous Leukemia
- Hemophagocytic Lymphohistiocytosis (HLH)
- Familial Hemophagocytic Lymphohistiocytosis (FLH)
- Viral-associated Hemophagocytic Syndrome (VAHS)
- X-linked Lymphoproliferative Disease (XLP)

## Interventions

- **DRUG:** Ara-C
- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** Campath-1H
- **RADIATION:** Total Body Irradiation
- **PROCEDURE:** Stem Cell Infusion

## Key facts

- **NCT ID:** NCT00368355
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2015-11
- **Final completion:** 2016-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-01-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368355, "T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00368355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*